Table 1.
Group | N | Vaccine dosagea | Vaccine given at months |
||||
---|---|---|---|---|---|---|---|
0 | 1 | 2 | 6 | 12 | |||
A | 6 | CN54gp140 + GLA-AF | + | + | + | + | − |
B | 6 | CN54gp140 + GLA-AF | + | + | + | − | + |
aVaccines: recombinant uncleaved clade C HIV-1 envelope gp140 protein (CN54gp140) administered intramuscularly into the deltoid muscle of the upper arm at a dosage of 100 µg CN54gp140 formulated with 5 µg glucopyranosyl lipid A-aqueous formulation in a total volume of 0.4 ml.